Molecular Therapy — Methods & Clinical Development · 2022 · 43 citations · 46 references
MedicineImmunologyOncologyCancer ImmunologyCell TherapyImmunotherapyCancer ImmunotherapyGlioblastomaImmunotherapy For Brain TumorsImmunotherapy For Solid TumorsNatural Killer Cell BiologyNatural Killer Cell TherapyCar-nk Cell TherapyChimeric Antigen Receptor Natural Killer CellsGlioblastoma ImmunotherapyHost Immune SuppressionImmune Suppression MechanismsNk Cell EngineeringTransforming Growth Factor Beta-mediated Immune SuppressionTumor Microenvironment Effects
. However, transforming growth factor (TGF)-β within the tumor microenvironment has devastating effects on the cytolytic activity of both unmodified and CAR-transduced NK cells. To overcome this potent immune suppression, we demonstrated that co-transducing NK cells with a B7H3 CAR and a TGF-β dominant negative receptor (DNR) preserves cytolytic function in the presence of exogenous TGF-β. This study demonstrates that a novel DNR and CAR co-expression strategy may be a promising therapeutic for recalcitrant CNS tumors like GBM.
46
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text
Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants
Loredana Ruggeri, Marusca Capanni, Elena Urbani et al. · Science · 2002 · 3.4K citations
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu, David Marín, Pinaki P. Banerjee et al. · New England Journal of Medicine · 2020 · 2.1K citations · Full text
Life Sciences, Immunology, Oncology +17